Mode
Text Size
Log in / Sign up

A systematic review protocol plans to assess AI readiness in Ghana Health Service contextsAI readiness in Ghana Health Service under review

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that this is a protocol only; no data on AI implementation outcomes are currently available.

This systematic review protocol outlines a planned study to assess organizational and technological readiness for artificial intelligence (AI) implementation within the Ghana Health Service (GHS). The scope specifically targets GHS and comparable low- and middle-income country contexts. The primary objective is to evaluate multi-dimensional readiness, while secondary outcomes include identifying barriers, facilitators, and existing AI applications.

The authors intend to synthesize evidence to inform national health policy for the Ghana Health Service. By evaluating current infrastructure and organizational capacity, the study aims to create a foundation for integrating AI technologies into healthcare systems in resource-limited settings.

Because this is a protocol, no data or results have been collected yet. The review has not been conducted, and therefore no conclusions regarding AI efficacy or readiness can be drawn at this time. The findings will eventually inform policy, but current evidence is limited to the proposed methodology.

Researchers have announced a plan to review the readiness of the Ghana Health Service (GHS) for using artificial intelligence (AI). The review will look at organizational and technological readiness, as well as barriers and facilitators to AI implementation. It will also examine existing AI applications and their outcomes in Ghana and similar low- and middle-income countries.

The review is still in the protocol stage, meaning no results are available yet. The goal is to create an evidence base that can inform national health policy for the GHS. The study does not report on sample size, follow-up, or any safety concerns because it has not been conducted.

Because this is a plan for a review, not actual findings, readers should not draw any conclusions about AI in healthcare from this announcement. The final review may provide useful insights once completed, but for now, there is no data to support or discourage AI use in Ghana's health system.

What this means for you:
This is a plan for a review; no results are available yet.

Common questions

What is the purpose of this review?

The review aims to assess organizational and technological readiness for AI implementation in the Ghana Health Service and identify barriers and facilitators to AI use.

Are there any results from this review?

No, the review is still in the protocol stage, meaning it has not been conducted yet. No results are available.

Who will this review help?

The review is intended to inform national health policy for the Ghana Health Service and may be relevant for other low- and middle-income countries.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Artificial intelligence (AI) holds transformative potential for public health systems in low- and middle-income countries. The Ghana Health Service (GHS), Ghana's principal public health implementing agency, faces persistent workforce capacity gaps, fragmented digital infrastructure, and nascent data governance frameworks that collectively constrain AI adoption. No systematic review has specifically examined the multi-dimensional organisational and technological readiness of the GHS for AI implementation. This systematic review will synthesise evidence on organisational and technological readiness for AI implementation within the GHS and comparable low- and middle-income country contexts, identify barriers and facilitators, document existing AI applications and implementation outcomes, and generate an evidence base to inform national health policy. A systematic review will be conducted following PRISMA 2020 guidelines with protocol registration in PROSPERO (CRD420261339477). A Population-Concept-Context (PCC) framework guides eligibility criteria. Searches were conducted across 15 bibliographic and supplementary sources. Two independent reviewers will conduct double-blind screening with inter-rater reliability assessed using Cohen's kappa, targeting a threshold of 0.80 or above as recommended for complex mixed-methods reviews. Quality appraisal will use validated design-specific tools. A convergent integrated mixed-methods synthesis incorporating thematic synthesis and structured narrative synthesis will be applied, with meta-analysis conducted where sufficient quantitative evidence permits. Certainty of evidence will be assessed using GRADE and GRADE-CERQual. Formal ethical approval is not required as this review analyses existing published evidence. Findings will be submitted for peer-reviewed publication and disseminated to the GHS, Ghana Ministry of Health, and WHO Ghana Country Office. https://www.crd.york.ac.uk/PROSPERO/view/CRD420261339477, identifier CRD420261339477.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.